% Oocyte Donation Pregnancyes (days 3)

Similar documents
A Tale of Three Hormones: hcg, Progesterone and AMH

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Poor & Hyper responders: what is the best approach?

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

(BMI)=18.0~24.9 kg/m 2 ;

Ivf day 6 estradiol level

Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer

Sample size a Main finding b Main limitations

Prof. Antonio Pellicer

Oocyte Freezing and Ovarian Tissue Cryopreservation:

IVF Protocols: Hyper & Hypo-Responders, Implantation

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

INDICATIONS OF IVF/ICSI

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Is it the seed or the soil? Arthur Leader, MD, FRCSC

Modified natural cycles: the Italian experience

Infertility treatment

Patient Price List. t: e: w:

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

Treatment of Poor Responders

Principles of Ovarian Stimulation

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR)

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study

(1.,, ) (2.,,, )

FERTILITY PRESERVATION IN BREAST CANCER PATIENTS: FOLLICULAR BIOMARKERS IN LETROZOLE ASSOCIATED OVARIAN HYPERSTIMULATION

Raoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF

Fertility in the 21 st Century Dr Leigh Searle

Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium

LOW RESPONDERS. Poor Ovarian Response, Por

Consultations and Assessment Fertility Specialist consultation 180 Ultrasound scan of uterus and ovaries 100 AMH measurement 80 Semen analysis 100

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

2017 United HealthCare Services, Inc.

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Article Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study

New York Science Journal 2014;7(4)

Dr Guy Gudex. Gynaecologist and Fertility Specialist Repromed. 9:05-9:30 Advances in Assisted Reproduction What s New?

Relevance of LH activity supplementation

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD

Laboratoires Genevirer Menotrophin IU 1.8.2

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

Hold On To Your Dreams

Infertility Clinical Guideline

Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY

Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles

Progesterone and clinical outcomes

Ovarian hyperstimulation syndrome (OHSS)

Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients

Study on Several Factors Involved in IVF-ET of Human Beings

Scientific Highlights: First world conference on luteinizing hormone in ART: Landing in Asia Pacific

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

The emergence of Personalized Medicine protocols for IVF.

Price List. Valid from 1 st April 2017

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Risk of premature luteinization in IVF cycles and its impact on clinical pregnancy rate

Središnja medicinska knjižnica

Use of clomiphene to prevent premature luteinizing hormone surge during controlled ovarian hyper stimulation

Best practices of ASRM and ESHRE

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

IN VITRO FERTILISATION (IVF)

Biology of fertility control. Higher Human Biology

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Use of in vitro maturation for fertility preservation

Understanding IVF Processes in Surrogacy

Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization

Current Evidence On Infertility Treatment

2013 Sep.; 24(3):

Fertility assessment and assisted conception


Original Article Effects of a low hcg dose of 2000 IU on clinical outcomes of high-responder women undergoing IVF/ICSI

10.7 The Reproductive Hormones

Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi

Ovarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization

Freeze-All Policy: Is It Right for Everyone?

The impact of HMG on follicular fluid hormone levels, embryo quality and IVF outcome

Progesterone vaginal capsule versus vaginal gel for luteal support in normoresponder women undergoing long agonist IVF/ICSI cycles

STIMULATION AND OVULATION TRIGGERING

Cycle Plan Page1 CYCLE PLAN TYPE CYCLE TYPE: Initial Plan Updated Plan Management Team Review Monitoring Review

MODULE 1: OVULATION INDUCTION IN NORMAL RESPONDERS, POOR RESPONDERS, AND HYPERRESPONDERS

Transcription:

Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo

Evolution of oocyte donation cycles 1500 1500 1000 58% 661 500 0 2000 2001 2002 2003 2004 2005 2006 Oocyte Donation Pregnancyes (days 3)

OOCYTE DONOR S PROTOCOLS We have analyzed with a P-R study, the influence in the use of agonist vs. antagonist of the GnRH in the ovarian stimulation in oocytes Donors. Parameters GnRHa Protocol Antagonist Protocol Prospective Randomized Number of cycles 1200 1200 ns BMI 23.5 24.1 ns Duration (days) 10.5 10.1 ns Gonadotrophin dose 2360 2245 ns E2 (hcg day) 2630 1520 <0.0505 P4 (hcg day) 0.9 0.8 ns Oocytes retrieved 19.4 18.6 ns Number of ET 2.09 2.01 ns Pregnancy rate (%) 58.2 56.1 ns Implantation ti rate (%) 33.8 31.6 ns Miscarriage rate (%) 11.3 12.1 ns

Different gonadotrophins- Long Protocol Using GnRH agonist we have analyzed different gonadotrophins protocols in a Prospective Randomized study Parameters hmg FSH FSH+LH Prospective Randomized Number of cycles 1000 1000 1000 ns BMI 23.1 22.5 23.7 ns Duration (days) 10.6 10.4 10.5 ns Gonadotrophin dose 2450 2500 2350 ns E2 (hcg day) 2850 2520 2710 ns P4 (hcg day) 0.9 1.01 0.9 ns Oocytes retrieved 19.3 18.7 19.5 ns Number of ET 2.01 1.9 2.0 ns Pregnancy rate (%) 57.2 56.8 59.1 ns Implantation rate (%) 32.1 33.5 33.33 ns Miscarriage rate (%) 11.1 11.7 11.3 ns

Low-dose hcg replacing the Gonadotrophins for Ovarian Stimulation 120 oocyte donors Group A (n= 30) Group B (n= 30) Group C (n= 30) Group D (n= 30) 200 FSH 100 FSH+100 hcg 50 FSH+200 hcg 200 hcg Start dose: 200 IU FSH When 1 follicle 14 mm, the gonadotrophin was changed according to the group

Low-dose hcg Protocol COH parameters A (n= 30) 200FSH B (n= 30) 100FSH+100hCG C (n= 30) 50FSH+200hC G D (n= 30) 200hCG Prospective Randomized Duration (days) 10.1 10.1 10.4 10.0 ns FSH dose (UI) 1797 ± 62 a,b 1488 ± 52 a 1428 ± 46 b 1218 ± 51 b a: p 0.001 b: p 0.0001 hcg dose (UI) - a 314 ± 18 a 588 ± 38 a 614 ± 25 a a: p 0.0001 E 2 - hcg day (pg/ml) 2493 ± 213 a,b 2853 ± 227 a,c 3149 ± 244 a,c 2269 ± 204 b,c b: p 0.04 a: p 0.01 c: p 0.01 P 4 - hcg day (ng/ml) 1.1 ± 0.2 1.1 ± 0.2 1.5 ± 0.3 1.0 ± 0.3 ns Number of oocytes retrieved 16.3 ± 1.5 a 19.1 ± 1.3 a 17.4 ± 1.6 a 12.3 ± 1.0 a a: p 0.04 We found lower E2 levels in te day of hcg administration in Group D. We also retrieved less oocytes in this Group

Low-dose hcg Protocol IVF outcome A (n= 41) B (n= 42) C (n= 31) D (n= 26) 200 FSH 100FSH+100hCG 50FSH+200hCG 200hCG Prospective Randomized Age (years) 39.9 ± 0.8 40.7 ± 0.6 39.4 ± 0.9 38.9 ± 0.9 ns Endometrium (mm) 9.4 ± 0.4 8.9 ± 0.3 9.1 ± 0.4 9.9 ± 0.9 ns Fertilization rate- ICSI (%) 72.0 ± 4.0 74.0 ± 3.0 75.0 ± 4.0 77.0 ± 4.0 ns Fertilization rate- FIV (%) 65.0 ± 80 8.0 67.0 ± 90 9.0 69.0 ± 10.00 85.0 ± 60 6.0 ns Number of embryos transferred 2,0 2,0 2,0 ± 0,1 2,0 ± 0,1 ns Pregnancy rate (%) 18/41 (44%) 20/ 42 (48%) 13/ 31 (42%) 19/ 26 (73%) p 0.01 Miscarriage rate (%) 3/ 18 (16.7%) 3/ 20 (15.0%) 2/ 13 (15.4%) 3/19 (15.8%) ns

For this part of the talk, we can conclude c that the young non sterile e donor women are going to have a very positive response to any ovarian stimulation protocol used

Previous experience 4In oocyte donation cycles, we observed that younger women who produced a significantly higher number of oocytes with significantly lower doses of gonadotrophins produced d embryos with a significantly ifi higher chromosomal abnormality rate. Mean Age Gonadotrophin dose Oocytes retrieved E2 levels (pg/ml) Chromosomally abnormal embryos Chromosomally abnormal embryos (%) (%) DONORS 26,5 * 2418 ** 25,4 *** 3347 79/140 (56.4) * CONTROL 31,3 3616 14,8 2492 25/67(37.3) *(p=0,01) 01) **(p=0,02) 02) ***(p=0,001) 001) 4The pattern shown in the table associates high ovarian response with increased frequency of chromosomally abnormal embryos. (Reis Soares et al.,, Fertility and Sterility 2003)

ADDITIONAL CONTRIBUTING INFORMATION In the study by Munné et al., 2006 It was found that the rate of chromosome abnormalities was higher In the oocyte donor group than in the non-donor group (p<0.001) 001) This could be due to the fact that the oocyte donor group has a higher response.

Can the percentage of aneuplodies be reduced by lowering the dosages of gonadotrophins in order to lower the high ovarian response?

Baart et al., 2007 A very interesting ti study in response to this question. (December 2002-August 2005) Conventional ovarian stimulation - Pituitary down-regulation with GnRH agonist - Fixed daily dose of 225 IU recombinant FSH Mild stimulation Fixed dose of 150 IU recombinant FSH GnRH antagonist

Baart et al., 2007 Conventional Mild OOCYTES 484(121 (12.1, 57) 5.7) 459 (8.3, 4.7) N embryos obtained 271 260 N embryos suitable for biopsy 184 (68) 157 (60) N embryos diagnosed 159 (86) 143 (91) Proportion of embryos with normal morphology 35% Abnormal embryos/embryos diagnosed 63% 35% 51% 63% 45% P. 0.04 P 0.016 Normal embryo/patient 1.8 1.8 NS With mild stimulation, the percentage of abnormal embryos was lower than with conventional stimulation. However, the average number of chromosomally normal embryos per patient was the same.

When each group was analyzed separately A conventional group showed no significant correlation between the number of oocytes obtained and abnormalities. Conventional Mild However, there was a positive correlation in the mild group. Baart et al., 2007

We are running a study with 10 donors 4Inclusion criteria oocyte donors: bage: g 18-35 years bbmi: 18-25 kg/m2 b No history of recurrent miscarriage or implantation ti failure bno PCO DONOR 1st Stimulation Conventional Dose DONOR 2nd Stimulation Half Dose PGD PGD

10 DONORS DONOR 1st Stimulation Conventional dose DONOR 2nd Stimulation Half Dose Agonist of GnRH - FSH 225 IU - LH 75 IU Agonist of GnRH - FSH 112 IU - LH 37.5 IU

When we compared the 10 donors using conventional stimulation vs. half doses, we found that: Conventional Half p Nº cycles 10 10 - Nº oocytes 203 (20.6, 2.2) 116 (12.0, 1.0) <0.05 Fertilization rate 78.3 82.4 NS No embryos analyzed 102 58 NS Nº abnormal embryos (%) 55 (54.5) 28 (49.1) NS Nº blastocyst D5 (%) 69 (67.6) 44 (75.9) NS Nº normal bl. (%) 39 (38.2) 24 (41.4) NS With l ti l ti f t bt i d b t With lower stimulation fewer oocytes were obtained, but the percentage of aneuploidies remained virtually the same.

10 DONORS High Responders 20 oocytes > 3000 pg/ml of E2 DONOR 1st Stimulation Conventional dose 5 women DONOR 2nd Stimulation Half Dose Normal Responders Agonist of GnRH - FSH 225 IU - LH 75 IU 5women go st o G Agonist of GnRH - FSH 112 IU - LH 37.5 IU

High Responders RESULTS Conventional Half p Nº cycles 5 5 - No. oocytes (mean, SEM) 125 (25.6,2.9) * 55 (11.6,1.5) * <0.05 Fertilization rate 84.8 80.5 NS No. embryos analyzed 63 29 - No. abnormal embryos (%) 32 (50.8) * 10 (34.5) * <0.05 No. blastocyst D5 (%) 46 (73.0) 24 (82.8) NS No. normal bl. (%) 27 (42.8) 16 (55.2) NS The results of high responders showed, that we significantly reduced the number of oocytes by almost half by lowering the doses. There was a significant decrease in chromosomal abnormalities with half stimulation protocols.

Normal Responders RESULTS Conventional Half p Nº cycles 5 5 - No. oocytes (mean, SEM) 76(152 (15.2, 1.1) 11) 62(12413) (12.4,1.3) NS Fertilization rate 69.2 84.0 NS No. embryos analyzed 38 28 - No. abnormal embryos (%) 23 (60.5) 18 (64.3) NS No. blastocyst D5 (%) 23 (59.0) 20 (69.0) NS No. normal bl. (%) 12 (31.6) 8 (28.6) NS The results for normal responders show that the number of oocytes is similar for the two types of stimulation. The number of chromosomal abnormalities is also similar for the two protocols. The number of normal blastocysts available from the tranfer is also similar

CONCLUSIONS 4This indicates that high responders react differently than normal responders when doses are lowered. 4In other words, there are fewer chromosomal abnormalities in this group.

Natural cycle In another study along these lines, which is extremely interesting, we studied the abnormal alterations in the embryos resulting from 15 donors without stimulation. - That means the Natural cycle. 15 DONORS 8 DONORS z 1 st 2 nd NATURAL CONVENTIONAL In 8 of them, we have completed a second cycle. This time with Conventional stimulation. Labarta et al., (unpublished data)

RESULTS Natural Conventional p Nº cycles 15 8 - Nº oocytes MII 15 (1.0, 0) 121 (18, 5) - Fertilization rate 100 66.1 NS No embryos analyzed 15 53 NS Nº abnormal embryos (%) 6 (40%) 24 (45.28) NS Nº normal bl. (%) 9 (60%) 27 (50.94) NS Surprisingly, the results show that in the natural cycle there was a high percentage of abnormal embryos (40%) which is similar to the percentage found in the conventional cycles (45,28%). But the number of normal blastocysts was much greater in the Conventional cycles. Labarta et al., (unpublished data)

RESULTS Natural Conventional p Nº Cycles 15 8 P Aneuploidies rate 40% 45,28% NS Clinical pregnancy rate 11,1% 71,4% 0,001 Implantation rate per ET 22,2% 66,6% 0,035 The clinical results further show that the pregnancy rate was much hhigher h in the conventional cycle than in the natural cycle. The implantation rate per embryo transfer was also much higher. Labarta et al., (unpublished data)

The current trend in IVF treatments is to stimulate ovulation as mildly as possible and the natural cycle is considered to be the most physiological. CONCLUSION Our clinical results for the natural cycle oblige us to use ovarian stimulation, but to also keep in mind that high responders may benefit from milder doses.